ATE377192T1 - Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls - Google Patents

Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls

Info

Publication number
ATE377192T1
ATE377192T1 AT00114788T AT00114788T ATE377192T1 AT E377192 T1 ATE377192 T1 AT E377192T1 AT 00114788 T AT00114788 T AT 00114788T AT 00114788 T AT00114788 T AT 00114788T AT E377192 T1 ATE377192 T1 AT E377192T1
Authority
AT
Austria
Prior art keywords
ovarian
detection
diagnostic method
adhesion molecule
endometrial tumors
Prior art date
Application number
AT00114788T
Other languages
English (en)
Inventor
Peter Altevogt
Mina Fogel
Original Assignee
Deutsches Krebsforsch
Mor Research Applic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch, Mor Research Applic Ltd filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of ATE377192T1 publication Critical patent/ATE377192T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57442—Specifically defined cancers of the uterus and endometrial
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70503—Immunoglobulin superfamily, e.g. VCAMs, PECAM, LFA-3
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00114788T 2000-07-10 2000-07-10 Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls ATE377192T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00114788A EP1172654B1 (de) 2000-07-10 2000-07-10 Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls

Publications (1)

Publication Number Publication Date
ATE377192T1 true ATE377192T1 (de) 2007-11-15

Family

ID=8169210

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00114788T ATE377192T1 (de) 2000-07-10 2000-07-10 Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls

Country Status (10)

Country Link
US (2) US7618785B2 (de)
EP (2) EP1172654B1 (de)
JP (1) JP5165827B2 (de)
CN (1) CN1479871A (de)
AT (1) ATE377192T1 (de)
AU (1) AU2001285820A1 (de)
CA (1) CA2415364C (de)
DE (1) DE60036935T2 (de)
ES (1) ES2296586T3 (de)
WO (1) WO2002004952A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1172654B1 (de) * 2000-07-10 2007-10-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls
US6852874B2 (en) 2000-10-02 2005-02-08 The Scripps Research Institute Second cycle asymmetric dihydroxylation reaction
EP1623995A1 (de) * 2004-08-06 2006-02-08 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Inhibitoren von L1 und ADAM10 zur Behandlung von Carzinoma
WO2007114550A1 (en) * 2006-04-03 2007-10-11 Korea Research Institute Of Bioscience And Biotechnology A novel monoclonal antibody specific to the l1cam, a hybridoma producing the same and a method producing the same
WO2008023947A1 (en) 2006-08-23 2008-02-28 Korea Research Institute Of Bioscience And Biotechnology A pharmaceutical composition for treating cholangiocarcinoma, a method for inhibiting growth or invasion of cholangiocarcinoma and a method for treating cholangiocarcinoma
US8138313B2 (en) * 2007-06-15 2012-03-20 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Treatment of tumors using specific anti-L1 antibody
AU2008201871A1 (en) * 2008-04-16 2009-11-26 Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts Inhibition of angiogenesis and tumor metastasis
KR20100060351A (ko) 2008-11-27 2010-06-07 한국생명공학연구원 Ｌ１ｃａｍ의 활성 또는 발현을 억제하는 물질 및 항암제를포함하는 항암용 조성물
WO2014077648A1 (ko) * 2012-11-16 2014-05-22 강원대학교산학협력단 인간 및 마우스 ｌ１ｃａｍ 단백질에 특이적으로 결합하는 항체 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939240A (en) * 1983-03-04 1990-07-03 Health Research, Inc. Monoclonal antibodies to human breast carcinoma cells and their use in diagnosis and therapy
GB2339200B (en) * 1998-06-06 2001-09-12 Genostic Pharma Ltd Genostics
EP1172654B1 (de) * 2000-07-10 2007-10-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Diagnostisches Verfahren für Eierstock- und Endometriumtumore basierend auf dem Nachweis des L1-Adhäsionsmoleküls
US20020115065A1 (en) * 2000-08-28 2002-08-22 Ton Logtenberg Differentially expressed epitopes and uses thereof
IL157492A0 (en) * 2001-02-21 2004-03-28 Univ Oklahoma Hla ligand database utilizing predictive algorithms and methods of making and using same

Also Published As

Publication number Publication date
CA2415364A1 (en) 2002-01-17
EP1172654A1 (de) 2002-01-16
JP5165827B2 (ja) 2013-03-21
US20040259084A1 (en) 2004-12-23
US20080138331A1 (en) 2008-06-12
US7670601B2 (en) 2010-03-02
EP1172654B1 (de) 2007-10-31
ES2296586T3 (es) 2008-05-01
AU2001285820A1 (en) 2002-01-21
CN1479871A (zh) 2004-03-03
WO2002004952A2 (en) 2002-01-17
WO2002004952A3 (en) 2003-11-06
US7618785B2 (en) 2009-11-17
DE60036935D1 (de) 2007-12-13
EP1386162A2 (de) 2004-02-04
DE60036935T2 (de) 2008-08-21
JP2004513074A (ja) 2004-04-30
CA2415364C (en) 2009-02-24

Similar Documents

Publication Publication Date Title
DE69939486D1 (de) Verfahren und vorrichtung für querflussassay
AU6275799A (en) Ykl-40 as a marker and prognostic indicator for cancers
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
DE69729156D1 (de) Verfahren zum Nachweis von Komplex-gebundenem Prostata-spezifischem Antigen (kPSA)
ATE365922T1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2002057787A3 (en) Detection of survivin in the biological fluids of cancer patients
ATE232559T1 (de) Verfahren zur signalverstärkung
WO2004112570A3 (en) Detection of survivin in the biological fluids of cancer patients
DE60025347D1 (de) Methoden zur vohersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
ATE377192T1 (de) Diagnostisches verfahren für eierstock- und endometriumtumore basierend auf dem nachweis des l1-adhäsionsmoleküls
DE69929785D1 (de) Verfahren zur Diagnose, Erkennung, und Einstufung von Dickdarmkrebs
DE69535273D1 (de) Detektionsvorrichtung und -verfahren
DE69941627D1 (de) Für krebs
WO2002064015A3 (en) Pin1 as a marker for prostate cancer
ATE173830T1 (de) Verfahren zur bestimmung der quantität extrazellulärer bpi in körperflüssigkeiten
ATE423852T1 (de) Methoden zur diagnose und prognose von krebs
ATE302416T1 (de) Auf holo-transcobalamin ii beruhendes diagnostisches verfahren für alzheimer-krankheit
BR9510669A (pt) Método para determinar ou detectar danos em órgão de doador em seguida ao xenotransplante com base em analitos derivados do órgão do doador
DE69625236D1 (de) Verfahren zur reihenuntersuchung auf prostatakrebs durch messung des apolipoprotein-d-spiegels in körperflüssigkeiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1172654

Country of ref document: EP